In vivo treatments with MLN0128, an mTOR inhibitor that exhibits antiproliferative activity, were successful in attenuating the growth of tumors and inducing apoptosis in mouse models injected with three different MCPyV-positive MCC cell lines [35]. The gene discussed is MTOR; the disease is Merkel cell skin cancer.